医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2013年
17期
8-9
,共2页
彭良欢%焦丽萍%毛善奎%朱灿宏%张三明
彭良歡%焦麗萍%毛善奎%硃燦宏%張三明
팽량환%초려평%모선규%주찬굉%장삼명
缬沙坦%老年人%高血压病%超敏C反应蛋白(hs-CRP)
纈沙坦%老年人%高血壓病%超敏C反應蛋白(hs-CRP)
힐사탄%노년인%고혈압병%초민C반응단백(hs-CRP)
Valsartan elderly hypertension%High-Senitivity%C-Reactive%Protein(hs -CRP)
目的观察缬沙坦治疗前后老年高血压病患者超敏C反应蛋白(hs-CRP)的变化;探讨缬沙坦对老年高血压患者超敏C反应蛋白的影响。方法150例老年高血压病2级患者和80例健康老年人进行hs-CRP测定。再将病例组随机分为A组和B组:A组给予缬沙坦(80mg,1次/d)治疗。B组给予氢氯噻嗪(12.5 mg,2次/d)治疗,监测两组患者血压均能控制在140/90mmHg以下,在给药前及给药3个月后进行hs-CRP测定。结果老年高血压病2级患者血清hs-CRP的含量高于对照组(P<0.05)。A组治疗后hs—CRP含量下降,并且下降程度高于B组(P<0.05)。结论老年高血压病患者hs-CRP增高,缬沙坦可降低hs-CRP的含量。
目的觀察纈沙坦治療前後老年高血壓病患者超敏C反應蛋白(hs-CRP)的變化;探討纈沙坦對老年高血壓患者超敏C反應蛋白的影響。方法150例老年高血壓病2級患者和80例健康老年人進行hs-CRP測定。再將病例組隨機分為A組和B組:A組給予纈沙坦(80mg,1次/d)治療。B組給予氫氯噻嗪(12.5 mg,2次/d)治療,鑑測兩組患者血壓均能控製在140/90mmHg以下,在給藥前及給藥3箇月後進行hs-CRP測定。結果老年高血壓病2級患者血清hs-CRP的含量高于對照組(P<0.05)。A組治療後hs—CRP含量下降,併且下降程度高于B組(P<0.05)。結論老年高血壓病患者hs-CRP增高,纈沙坦可降低hs-CRP的含量。
목적관찰힐사탄치료전후노년고혈압병환자초민C반응단백(hs-CRP)적변화;탐토힐사탄대노년고혈압환자초민C반응단백적영향。방법150례노년고혈압병2급환자화80례건강노년인진행hs-CRP측정。재장병례조수궤분위A조화B조:A조급여힐사탄(80mg,1차/d)치료。B조급여경록새진(12.5 mg,2차/d)치료,감측량조환자혈압균능공제재140/90mmHg이하,재급약전급급약3개월후진행hs-CRP측정。결과노년고혈압병2급환자혈청hs-CRP적함량고우대조조(P<0.05)。A조치료후hs—CRP함량하강,병차하강정도고우B조(P<0.05)。결론노년고혈압병환자hs-CRP증고,힐사탄가강저hs-CRP적함량。
Objective To investigate the changing levels of High-Senitivity C-Reactive Protein(hs-CRP) before and after using Valsartan in patients with elderly hypertension in order to explore the effects of Valsartan on serum hs-CRP .Methods Hs-CRP contents of 150 patients with elderly hypertension 2 and 80 healthy elderly were detected. The 150 patients were randomly divided into two groups: Group A (number=76)was given 80mg Valsartan every day; Group B(number=74) was given 12.5mg hydrochlorothiazide twice every day. Al the patients’ Blood pressure were wel controled under 140/90mmHg. After three months we detected the hs-CRP contents of each group again.ResultsThe serum levels of hs-CRP of patients with elderly hypertension 2 were higher than those in controls(P<0.05). The serum levels of hs-CRP in post therapy patients of group A were decreased, and it were lower than those in group B(P<0.05).ConclusionsThe hs-CRP contents of patients with elderly hypertension were increased, and Valsartan could reduce it.